News from the healthcare data industry
With a focus on evidence-generating medicine, Osmind brings scientific rigor to the medical community focused on advanced interventions for moderate to severe mental health conditions, including ketamine therapy, SPRAVATO®, psychedelic...
Data demonstrates that intravenous ketamine is a rapid and robust treatment for depression. These results can inform clinical best practices and provide real-world evidence to advocate for better insurance coverage.January...
SAN FRANCISCO–(BUSINESS WIRE)–Osmind, the healthcare technology company and Public Benefit Corporation that is building the first digital infrastructure for neuropsychiatry and provides the #1 Electronic Health Record (EHR) software for...